Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. DEFA14A Proxy Proxy Materials
  2. CT ORDER Other Confidential Order
  3. S-3ASR Offering Registration Statement
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. CT ORDER Other Confidential Order
  6. CT ORDER Other Confidential Order
  7. CT ORDER Other Confidential Order
  8. DEFA14A Proxy Proxy Materials
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. CT ORDER Other Confidential Order
  11. EFFECT Other Notice of Effectiveness
  12. CERTNAS Other Certification by the Nasdaq Stock Market
  13. 8-A12B Other Registration of Securities
  14. DRS/A Other Draft Registration Statement
  15. DRSLTR Other Correspondence Related to Draft Registration Statement
  16. DRS/A Other Draft Registration Statement
  17. DRS Other Draft Registration Statement

Page 6 of 6 · 117 filings